United Kingdom · Question · Written question
UIN 77281
Tofersen
Introduced
15 September 2025
Last action
13 October 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
13 October 2025
Summary
To ask the Secretary of State for Health and Social Care, what discussions he has had with NHS England on ensuring adequate numbers of NHS employees are available to administer Tofersen.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
15 September 2025
Written question
To ask the Secretary of State for Health and Social Care, what discussions he has had with NHS England on ensuring adequate numbers of NHS employees are available to administer Tofersen.
Source: Commons
13 October 2025
Answer
I have had no such discussions. The National Institute for Health and Care Excellence (NICE) has selected tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations as a topic for guidance development through its Highly Specialised ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-09-15/77281
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1835176
- uk · wq-1835176 · source updated 13 October 2025